Newsfiscal.ai
Scinai Immunotherapeutics Reports Nine-Month 2026 Financial Results and CDMO Expansion
· Published
Article summary
Scinai announced a 167% increase in revenue for the first nine months of 2026 and an expanded U.S. customer agreement for its CDMO subsidiary.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…